12 results
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
and stock price appreciation targets, and designed to foster strong alignment between our employees and stockholder interests.
Time-based
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
meaningful, differentiated benefits for patients by improving upon the efficacy and/or safety of existing therapeutics directed against established targets … and policies agreed to by the FDA under PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review
10-Q
x5pbgb6nms7
15 Jun 23
Quarterly report
4:19pm
424B4
640m5o09q
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
8xo5dmnw7 0vs2wh
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.14
lnuhyysxejs5gvh0d
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.3
hw7dvk5
1 May 23
IPO registration (amended)
6:10am
S-1
um0aw7b
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next